Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Sept 2026 for BriaCell Therapeutics Corp.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Gadi Levin: trading record in brief
Gadi Levin discloses dealings in 3 companies, chiefly BriaCell Therapeutics Corp., A2Z Cust2Mate Solutions Corp. and Briapro Therapeutics Corp. We count 14 filings; the first trade dates from 1 February 2016 and the latest from 31 July 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 28 September 2026: a share grant, in BriaCell Therapeutics Corp. The median gap between a trade and its publication by SEC (Form 4) is 40 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gadi Levin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
8,242 sharesPerformance Share UnitsTSXSEDI:4782198
25,257 sharesPerformance Share UnitsTSXSEDI:4782195
84,775 sharesPerformance Share UnitsTSXSEDI:4782194
94,194 sharesPerformance Share UnitsTSXSEDI:4782192
Performance Share UnitsTSXSEDI:4782190
1,438,000 sharesRestricted Stock UnitsTSXSEDI:4780851
Restricted Stock UnitsTSXSEDI:4780850
230,000 sharesRights Restricted Share UnitsTSXSEDI:4751715
Rights Restricted Share UnitsTSXSEDI:4751714
Common SharesTSXSEDI:4751713
28,257 sharesCommon SharesTSXSEDI:4748069
1,438,000 sharesCommon SharesTSXSEDI:4701047
84,943 sharesCommon SharesTSXSEDI:4566608
94,194 sharesCommon SharesTSXSEDI:4565258
14 of 14 declarations
